Across TCGA pan-cancer cohorts, RNU6-768P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-768P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-768P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-768P expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

STAD, TGCT, and ESCA are the cancer types where RNU6-768P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.083	0.379	.001	45	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
ESCA	DFS	Tertile	All	0.148	0.673	.040	18	view →
KIRC	DFS	Median	III,IV	0.709	0.554	.026	8	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-768P tumor-vs-normal RNA expression · all RNU6-768P data types